J. N’takpé

发表

Standard dose raltegravir or efavirenz-based antiretroviral treatment for patients co-infected with HIV and tuberculosis (ANRS 12 300 Reflate TB 2): an open-label, non-inferiority, randomised, phase 3 trial.

C. Delaugerre, S. Eholie, E. Messou, 2021, The Lancet. Infectious diseases.

Association between cellular HIV-1 DNA level and mortality in HIV-1 infected African adults starting ART with high CD4 counts

C. Rouzioux, S. Eholie, X. Anglaret, 2020, EBioMedicine.

High prevalence of being Overweight and Obese HIV-infected persons, before and after 24 months on early ART in the ANRS 12136 Temprano Trial

D. Ekouevi, S. Eholie, X. Anglaret, 2016, AIDS Research and Therapy.

Inhaled ciclesonide for outpatient treatment of COVID-19 in adults at risk of adverse outcomes: a randomised controlled trial (COVERAGE)

J. Durrieu, J. Montastruc, J. Chastang, 2022, Clinical Microbiology and Infection.

Antiretroviral treatment regardless of CD4 count: the universal answer to a contextual question

S. Eholie, X. Anglaret, C. Danel, 2016, AIDS Research and Therapy.

High prevalence of being Overweight and Obese HIV-infected persons, before and after 24 months on early ART in the ANRS 12136 Temprano Trial

D. Ekouevi, S. Eholie, X. Anglaret, 2016, AIDS Research and Therapy.

Decrease in sexual risk behaviours after early initiation of antiretroviral therapy: a 24-month prospective study in Côte d'Ivoire

F. Lert, S. Eholie, X. Anglaret, 2014, Journal of the International AIDS Society.

High correlation between Framingham equations with BMI and with lipids to estimate cardiovascular risks score at baseline in HIV-infected adults in the Temprano trial, ANRS 12136 in Côte d’Ivoire

Xavier Anglaret, S. Eholie, X. Anglaret, 2017, PloS one.

Elite and viremic HIV-1 controllers in West Africa

C. Rouzioux, O. Lambotte, S. Eholie, 2021, AIDS.

WHO guidelines for antiretroviral therapy in serodiscordant couples in sub-Saharan Africa: how many fit?

S. Eholie, X. Anglaret, C. Danel, 2014, AIDS.

High prevalence of being Overweight and Obese HIV-infected persons, before and after 24 months on early ART in the ANRS 12136 Temprano Trial.

D. Ekouevi, S. Eholie, X. Anglaret, 2016, AIDS research and therapy.